Regenxbio Shares Rise in Premarket As Duchenne Gene Therapy Shows Treatment Benefit

Shares of  Regenxbio rose Monday in premarket trading after the company said its treatment for Duchenne muscular dystrophy delivered positive trial results, strengthening the case for a speedier ...

Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals

Vamorolone is approved and marketed as AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD) in the US, European Union, UK and ChinaNew ...
News Medical

Gene Editing for Muscular Dystrophy

Muscular Dystrophies are a group of genetic conditions characterized by muscle weaknesses. They are genetic conditions and have different sub-categories depending on which area of muscle mass is ...
Hosted on MSN

Struggling With Muscle Weakness? It May Be A Sign Of Muscular Dystrophy

Muscular Dystrophy (MD) is more than a medical condition—it's a journey that reshapes lives. Imagine trying to climb stairs, run, or even stand, only to find your muscles not cooperating. That’s the ...
Everyday Health

Speaking Muscular Dystrophy: A Glossary of Terms Used to Describe Symptoms, Tests, Treatments, and More

This quick alphabetical guide will help you feel more confident when talking about muscular dystrophy with your doctor and loved ones. Muscular dystrophy is the name for a group of genetic diseases ...
KSDK

'You aren't alone': Families reunite at annual Muscle Walk against muscular dystrophy

ST. LOUIS — When families streamed into Forest Park Sunday morning, many of them were there for a walk to cover new ground in the fight against muscular dystrophy. "You know for me the diagnosis was ...

PPMD Team Member Wins Two Races at 2026 Walt Disney World(R) Marathon Weekend Presented by State Farm

PPMD extends its heartfelt thanks to all Race to End Duchenne runners, donors, and volunteers who made the 2026 Walt Disney World (R) Marathon Weekend a memorable and meaningful success. To learn more ...